Evercore ISI analyst Glenn Schorr maintained a Hold rating on Northern (NTRS – Research Report) today and set a price target of $113.00. The ...
In a report released yesterday, John Pancari from Evercore ISI maintained a Hold rating on Comerica (CMA – Research Report), with a price ...
Julian Emanuel of Evercore ISI says Trump's economic policies will be moderated and influenced by the bond markets. His does not see a significant downturn in the U.S. economy, explaining his S ...
In conclusion, despite the dynamic nature of the data center cooling market, Evercore ISI believes that Vertiv is well-equipped to meet the increasing demand for efficient thermal and power ...
Evercore ISI analyst Amit Daryanani lowered the firm’s March-end quarter estimates for Seagate (STX) after the company filed an 8-K on December 3, noting they are experiencing some delays in ...
On Tuesday, Evercore ISI analysts downgraded Dentsply Sirona stock from Outperform to In Line, adjusting the price target to $20.00. The decision was influenced by uncertainties surrounding the dental ...
Evercore ISI expressed on Friday that Wall Street will likely see more of what it experienced in 2024, as the investment institution stated “Fill IT up again” in 2025 indicating its positive ...
NEW YORK, January 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025. The power & utilities sector is rapidly ...
Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025. The company ...
Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025.
Shares of Spero Therapeutics stock opened at $0.96 on Friday. Spero Therapeutics has a 12 month low of $0.95 and a 12 month high of $1.89. The business has a 50-day moving average of $1.20 and a ...
Thursday, Evercore ISI raised its rating for Canadian National Railway (TSX:CNR) (NYSE:CNI) to Outperform from In Line, also increasing the price target to $123.00 from $116.00. The firm sees a ...